Program

The provisional program (subject to minor change) can be found below:

Download the program

Confirmed Speakers

Judith Agudo (Dana-Farber Cancer Institute, USA)
Ana Luisa Correia (Champalimaud Foundation, Portugal)
Ayelet Erez (Weizmann Institute of Science, Israel)
Ayuko Hoshino (University of Tokyo, Japan)
Benjamin Izar (Columbia University, USA)
Charles Swanton (Francis Crick Institute, UK)
Christina Curtis (Stanford University, USA)
Clare Isacke (Institute of Cancer Research, UK) – MRS Women in Science Awardee
Daniela Quail (McGill University, Canada)
David Entenberg (Einstein College of Medicine, USA)
David Lyden (Weill Cornell Medical College, USA) – MRS Paget Ewing Awardee
Eduard Batlle (IRB Barcelona, Spain)
Erica Sloan (Monash University, Australia)
Guillaume Jacquemet (Åbo Akademi University, Finland)
Humsa Venkatesh (Brigham and Women’s Hospital, USA)
Karuna Ganesh (Memorial Sloan Kettering Cancer Center, USA) – MRS Sue Eccles ECR Awardee
Ilaria Malanchi (Francis Crick Institute, UK)
Mariam Jamal-Hanjani (University College London, UK)
Mikala Egeblad (Johns Hopkins University, USA) – MRS Fidler Innovation Awardee
Nicola Aceto (ETH Zurich, Switzerland)
Sanne Schagen (Netherlands Cancer Institute, Netherlands)
Sean Morrison (UT Southwestern, USA)
Sherene Loi (PeterMac Cancer Centre, Australia)

Abstracts

Submit your abstract

Abstracts should be submitted via the online form here.

Attendance at the meeting also requires registration.

The final abstract submission deadline is 30th April 2024.

Accommodation

Travel accommodation is not included with your registration fee and must be arranged separately by the attendee.

The local area around the Crick Institute has numerous hotels within easy walking distance. The following are suggestions for consideration.

• Hub by Premier Inn
• London King’s Cross hotel
• London St Pancras Premier Inn
• Bloomsbury Holiday Inn
• Hilton – London Euston

We advise booking early as Taylor Swift is in town at the same time and demand for hotels is likely to be high.

Early Career Researcher Programme

Registration for the main biennial congress is required to attend the Early Career Workshops.
The Early Career Workshops are free to those who have registered for the main meeting.

Once registered, please complete the following form here to confirm your attendance at the ECR Workshops

The Early Career Leadership Council of the MRS, together with the MRS Board, are putting together a series of short sessions specifically aimed at Early and Mid-Career researchers (i.e. undergraduate and postgraduate students, postdoctoral fellows, medical residents and junior research staff). These will flank the meeting on the afternoon of 22nd June and morning of 26th June and will include short talks from selected abstracts, networking opportunities, Meet the Experts sessions, and panel discussions with leaders in the field.

Tentative schedule (subject to minor changes):

Saturday June 22, 2024
2:00pm     Welcoming remarks
2:15pm     “Match-making” session to meet others with similar research interests
3:00pm     Coffee break
3:30pm     Short talks
5:00pm     Meet the Experts (parallel sessions)

Wednesday June 26, 2024
9:00am      Short talks
10:30am    Break
10:45am    Panel discussion: Hot Topics in Metastasis Research
11:30am     Short talks
12:30pm    Lunch
1:30pm      Panel discussion: The Future of Metastasis Research
2:15pm      Closing Remarks

What is MetARP?

The MRS Advocate Researcher Program (MetARP) – hosted by the Metastasis Research Society and Theresa’s Research Foundation with support from BCRF aims to build bidirectional relationships between researchers and advocates at the upcoming Metastasis Research Society Biennial Meeting in London.

With a range of engagement initiatives planned over the course of the meeting, and travel support available, please see here for further information and details on how to apply.

Conference Poster

Click on the poster below to access a high resolution copy you can download, print and share

Code of Conduct

All delegates, speakers, partners and sponsors at any MRS event agree to the following code of conduct.
Organisers will enforce this code throughout the event.

The Metastasis Research Society is dedicated to providing a harassment-free conference experience for everyone, regardless of gender, sexual orientation, disability, physical appearance, body size, race, or religion. Harassment of anyone, in any form, is not tolerated. Sexual language and imagery is inappropriate, including in conference sessions.

Event participants violating these rules may be sanctioned or expelled from the conference without a refund at the discretion of the conference organisers.

Harassment includes offensive verbal comments related to gender, sexual orientation, disability, physical appearance, body size, race, religion, sexual images in public spaces, deliberate intimidation, stalking, following, harassing photography or recording, sustained disruption of talks or other events, inappropriate physical contact, and unwelcome sexual attention.

Sponsors are also subject to the anti-harassment policy.

Participants asked to stop any harassing behaviour are expected to comply immediately.

If a participant engages in harassing behaviour, the conference organizers may take any action they deem appropriate, including warning the offender or expulsion from the conference without refund.

If you are being harassed, notice that someone else is being harassed, or have any other concerns, please contact a member of conference staff or the MRS board immediately.

We expect participants to follow these rules at all conference venues and conference-related social events.